Quince Therapeutics, Inc.

QNCX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$6,212$20,752$44,579$69,724
Short-Term Investments$34,572$54,307$45,602$37,078
Receivables$882$993$0$1,128
Inventory$0$0$0$0
Other Curr. Assets$2,370$1,388$3,567$3,743
Total Curr. Assets$44,036$77,440$93,748$111,673
Property Plant & Equip (Net)$813$619$684$1,428
Goodwill$0$17,625$0$0
Intangibles$60,045$63,672$5,900$0
Long-Term Investments$78$78$3,578$19,933
Tax Assets$0$12,304-$3,578$0
Other NC Assets$9,506$8,466$3,578$194
Total NC Assets$70,442$102,764$10,162$21,555
Other Assets$0$0$0$0
Total Assets$114,478$180,204$103,910$133,228
Liabilities
Payables$2,903$2,033$570$4,911
Short-Term Debt$96$64$453$741
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$4,279$7,475$2,046$8,570
Total Curr. Liab.$7,278$9,572$3,069$14,222
LT Debt$14,715$13,750$0$420
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$4,963$17,608$248$0
Other NC Liab.$57,376$54,190$0$0
Total NC Liab.$77,054$85,548$248$420
Other Liabilities$0$0$0$0
Cap. Leases$490$321$453$1,161
Total Liabilities$84,332$95,120$3,317$14,642
Equity
Pref Stock$0$0$0$0
Common Stock$44$43$36$30
Retained Earnings-$376,472-$319,644-$288,259-$236,599
AOCI-$35$3,047-$289-$79
Other Equity$406,609$401,638$389,105$355,234
Total Equity$30,146$85,084$100,593$118,586
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$114,478$180,204$103,910$133,228
Net Debt$8,599-$6,938-$44,126-$68,563
Quince Therapeutics, Inc. (QNCX) Financial Statements & Key Stats | AlphaPilot